Lodi’s diagnostics engine just kicked into a higher gear. Cepheid has cut the ribbon on Building 5, a new 180,000‑square‑foot warehouse at its North Guild Avenue manufacturing campus that opened May 28, 2026. The latest facility completes a multi‑building build‑out that pulls cartridge assembly, packaging and distribution together in one place, further rooting a growing cluster of life‑science manufacturing jobs in the city.
As reported by Sacramento Business Journal, Building 5 is the newest addition to the Lodi campus. Cepheid also announced the opening on LinkedIn, calling the facility a “central warehouse” where customer orders are prepared before test kits are shipped worldwide. Taken together, the pieces underscore Cepheid’s push to make Lodi its end‑to‑end manufacturing base for diagnostic cartridges.
A $200M Build‑Out Comes Together
The Lodi expansion caps a multi‑year investment of roughly $200 million that came with help from the state. The California Alternative Energy and Advanced Transportation Financing Authority authorized up to $209.75 million in qualified property for Cepheid’s project, according to the agency’s staff summary.
That money helped turn the campus into something far more sophisticated than a basic warehouse complex. The site now includes production cleanrooms, automated assembly lines, automated packing lines and quality labs, infrastructure that converts plastic cartridges into finished diagnostic tests at scale, according to Lodi411. Building 5 slots into that ecosystem as the final logistics piece that ties the operation together.
Jobs And The Sunnyvale Shift
The Lodi build‑out did not happen in a vacuum. It followed a period of consolidation in which Cepheid shifted much of its cartridge manufacturing out of the Bay Area. MedTech Dive reported that the company filed WARN notices and cut hundreds of California jobs in Sunnyvale as part of that transition.
Centralizing more work in Lodi is intended to pay off on the customer side. The new warehouse is designed to smooth logistics and shorten lead times for hospitals and public‑health buyers, a need also highlighted by the Sacramento Business Journal. In practical terms, the company wants test kits moving from production line to loading dock with fewer handoffs in between.
What Comes Next For Lodi
Manufacturing advocates see the project as a high‑profile win for California’s life‑science sector. The California Manufacturers & Technology Association has recently spotlighted Cepheid’s role statewide, pointing to the company as an example of advanced manufacturing sticking with California rather than bolting for cheaper ground.
At the same time, Lodi411 and company statements note that Cepheid is broadening its test menu and partnerships. The company says the Lodi campus will be the source for finished diagnostic cartridges shipped to hospitals and public‑health partners around the world, a global reach that now runs straight through a newly completed warehouse on North Guild Avenue.
